Recombinant Human DCXR Protein，His

DCXR (Dicarbonyl/L-xylulose reductase) is an enzyme that plays a crucial role in the metabolism of reactive dicarbonyl compounds and the conversion of L-xylulose to D-xylulose, which is essential in the pentose phosphate pathway. Researchers have shown that DCXR is implicated in various physiological and pathological processes, including diabetes and its complications, as well as cellular stress responses due to its ability to reduce toxic dicarbonyls. This enzyme is of particular interest because it can impact the formation of advanced glycation end-products (AGEs) that contribute to diabetic complications and age-related diseases. Despite its potential therapeutic significance, the detailed biochemical properties and structural characteristics of DCXR remain underexplored, necessitating further investigation. Recent studies have aimed to express and purify recombinant DCXR to better understand its kinetic behavior, substrate specificity, and role in cellular defense mechanisms against oxidative stress. The recombinant forms of the enzyme are also being examined for their potential applications in biotechnology, particularly in the development of drugs and therapeutic strategies targeting dysregulated dicarbonyl levels in tissues. This research direction holds promise for advancing knowledge of metabolic dysregulation in diabetes and other diseases while offering insights into potential interventions that leverage the unique properties of DCXR.